24 results on '"Tol, J."'
Search Results
2. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
3. 161P DESCARTES trial: De-ESCAlating RadioTherapy in patients with pathologic complete response to neoadjuvant systemic therapy
4. 233P Treatment pattern and outcomes for the first two lines of chemotherapy in patients diagnosed with metastatic triple-negative breast cancer, results from the Dutch SONABRE Registry
5. 219P Chemotherapy use and survival outcomes for patients diagnosed with metastatic hormone receptor-positive HER2-negative breast cancer, results from the Dutch SONABRE registry
6. 395P Receptor status heterogeneity during metastatic breast cancer treatment
7. 352P Cost-effectiveness of CDK4/6 inhibitors in first- vs second-line for advanced breast cancer (ABC) in the phase III SONIA trial (BOOG 2017-03)
8. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
9. 392P The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer on first-line endocrine therapy with or without a CDK 4/6 inhibitor
10. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
11. 180P A doubling in overall survival of patients with de novo HER2+ advanced breast cancer in the Netherlands
12. 179P Time trends in overall survival and systemic therapy in patients with HR+/HER2- advanced breast cancer: A study of the SONABRE registry
13. LBA79 Dutch oncology COVID-19 Consortium (DOCC): Outcome of COVID-19 in patients with cancer in a nationwide cohort study
14. Antiferromagnetic resonance of polycrystalline BiMn2O5
15. 1818P - Simultaneous intravenous fluid infusion to prevent oxaliplatin infusion-related venous pain
16. Short- and long-term outcomes in 1438 consecutive pancreatoduodenectomies: a single-center 25-years' experience
17. Outcome and survival after distal pancreatectomy for pancreatic ductal adenocarcinoma: a nationwide cohort study
18. Impact of muscle mass and muscle density on outcomes after pancreatoduodenectomy for periampullary cancer
19. The value of isokinetic testing and MRI for return to sport decision making in acute hamstring injuries
20. The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
21. 6011 Calcium and magnesium (Ca/Mg) infusions to reduce oxaliplatin- induced neurotoxicity and outcome in advanced colorectal cancer (ACC) patients (pts) treated with oxaliplatin- and cetuximab-based therapy
22. 6002 BRAF mutation is associated with a decreased outcome in patients (pts) with advanced colorectal cancer (ACC) treated with chemotherapy and bevacizumab with or without cetuximab
23. 3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis
24. Characterizing landfill leachate migration potential of a semi-arid duplex soil.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.